Scientific Advisory Committee

Made up of 12 of the most prestigious physicians and scientists in the United States, the Scientific Advisory Committee (SAC) oversees PKD Foundation research and medical programs aimed at discovering and delivering treatments for PKD. The SAC meets several times throughout the year to discuss relevant medical issues, provide guidance to PKD Foundation staff and review and approve research applications for grants and fellowships in the field of PKD science. All PKD Foundation materials and publications are approved by SAC members, who possess the highest level of experience and knowledge in PKD clinical and scientific work.

 

Effective July 1, 2014:

 

Officers

Terry WatnickTerry Watnick, M.D. – Chair
The University of Maryland

Dr. Terry Watnick lives in Chevy Chase, Maryland. She is an Associate Professor of Medicine in the Division of Nephrology at the University of Maryland, where she established an inherited renal disease clinic. She has also been an investigator in several multicenter clinical trials, recruiting patients with ADPKD, including TEMPO. She moved to the University of Maryland School of Medicine in 2012 where she leads the Baltimore Polycystic Kidney Disease Research and Clinical Core Center. She currently serves as the SAC Chair for the PKD Foundation’s Board of Trustees. Dr. Watnick received her medical degree from The Yale School of Medicine and completed her Internal Medicine training at Yale-New Haven Hospital. She then moved to the Johns Hopkins Hospital where she received Clinical Training in Nephrology. She also completed a research fellowship that was focused on the genetics of ADPKD. Dr. Watnick subsequently joined the faculty at the Johns Hopkins School of Medicine where she rose through the ranks to Associate Professor. During this time she continued to develop her clinical and research interests in Inherited Kidney Diseases.

Stefan Somlo, M.D. – Vice Chair
Yale University School of Medicine 

Members

Benjamin D. Cowley, Jr., M.D. – Former Chair
University of Oklahoma Health Sciences Center

John J. Bissler, M.D.
University of Tennessee Health Sciences Center

Alessandra Boletta, Ph.D.
San Raffaele Scientific Institute - Milan, Italy

Iain Drummond, Ph.D.
Massachusetts General Hospital
Harvard Medical School

Michal Mrug, M.D.
University of Alabama at Birmingham SOM

York Pei, M.D.
Toronto General Hospital
University Health Network

Ronald D. Perrone, M.D.
Tufts Medical Center

Richard Sandford, Ph.D., FRCP
University of Cambridge
Cambridge Institute of Medical Research

Darren Wallace, Ph.D.
University of Kansas Medical Center

Angela Wandinger-Ness, Ph.D.
University of New Mexico Health Sciences Center


 

Stefan Somlo, M.D.
Yale University School of Medicine

C.N.H. Long Professor of Medicine (Nephrology) and Professor of Genetics; Chief, Section of Nephrology - Research Interests: Genetic kidney and liver disease;  Cilia function in tissue homeostasis;  Polycystin function

 

Benjamin D. Cowley, Jr., M.D.
University of Oklahoma Health Sciences Center

Has been Section Chief of Nephrology in the Department of Medicine since March, 2002, and is also the John Gammill Professor in Polycystic Kidney Disease. He is the Chair of the Scientific Advisory Committee of the Polycystic Kidney Disease Foundation and also the President, Board of Directors, for the Oklahoma Foundation for Kidney Disease. Serves on the Board of Directors of LifeShare Transplant Donor Services of Oklahoma and is currently the UNOS designated physician for the OU Mecical Center Kidney Transplant Program and the OU Medical Center Pancreas Transplant Program

 

John J. Bissler, M.D.
University of Tennessee Health Sciences Center

Board certified in Pediatrics and Pediatric Nephrology with expertise in Angioedema, Kidney Disease, and Tuberous Sclerosis.  Left the Cincinnati Children's Hospital in September 2013 (Cincinnati will no longer be seeing Renal Adult patients) and moved to the University of Tennessee, Le Bonheur Pediatric Hospital and St. June Pediatric Research Hospital.

 

Alessandra Boletta, Ph.D.
San Raffaele Scientific Institute -- Milan, Italy

Director, Division of Genetics and Cell Biology, Head of Research Unit

 

Iain Drummond, Ph.D.
Massachusetts General Hospital, Harvard Medical School

Associate Professor, Department of Medicine, Harvard Medical School / Associate Biologist, Renal Unit, Massachusetts General Hospital

 

Michal Mrug, M.D.
University of Alabama at Birmingham SOM

Associate Professor, Internal Medicine/Nephrology

  

York Pei, M.D.
Toronto General Hospital, University Health Network

Professor of Pathology and Associate Professor of Obstetrics, Gynecology, and Reproductive Sciences; Director, Clinical Molecular Diagnostics; Director, Gynecologic Pathology

 

Ronald D. Perrone, M.D.
Tufts Medical Center

Associate Chief, Division of Nephrology; Medical Director, Kidney Transplantation; Professor, Tufts University School of Medicine.  2012 "Top Doctor" (Boston Magazine), 2012 "Top Doctor" and in top 1% in the nation in his specialty (U.S. News & World Report)

 

Richard Sandford, Ph.D., FRCP
University of Cambridge, Cambridge Institute of Medical Research

Consultant Clinical Geneticist with a special interest in inherited renal and liver disease, with a particular interest in autosomal dominant polycystic kidney disease

 

Darren Wallace, Ph.D.
University of Kansas Medical Center

Dr. Wallace is an Associate Professor in the Department of Medicine and the Kidney Institute at the University of Kansas Medical Center.  He received his PhD from the Department of Molecular and Integrative Physiology at KUMC in 1998 and joined the faculty of the Department of Medicine in 2002.  Dr. Wallace’s research is funded by an R01 grant from the National Institutes of Health (NIDDK).  He is the Director of the PKD Research Biomaterials and Cellular Models Core funded by the PKD Foundation. Additional research support is derived from private foundations and biotechnology companies.  Dr. Wallace is also a member of the Scientific Advisory Committee for the PKD Foundation.

 

Angela Wandinger-Ness Ph.D.
University of New Mexico Health Sciences Center

Director of Fluorescence Microscopy and Cell Imaging Shared Resource, and Professor in Department of Pathology.  Interests include:

GTPases as targets of small molecules therapeutics for ovarian cancer and genetic diseases;  Cellular & molecular basis of autosomal dominant polycystic kidney disease;  Renal stem cells;  Interrelationships between membrane trafficking, signaling cell polarity and disease pathology;  and Molecular mechanisms of Rab GTPases and lipid  signaling in membrane trafficking.

Your Organization

2000 Daniel Island Drive, Charleston SC 29492
Phone: 800.443.9441 | Fax: 843.216.6100
info@yourdomain.org

©2014, PKD Foundation ·The PKD Foundation is a 501 (c)(3), 509 (a)(1) public charity.

©2014, PKD Foundation ·The PKD Foundation is a 501 (c)(3), 509 (a)(1) public charity.

The PKD Foundation is a 501 (c)(3), 509 (a)(1) public charity.
National Headquarters: 8330 Ward Parkway, Suite 510, Kansas City, MO 64114. Phone: 1.800.PKD.CURE
©2014 PKD Foundation. Privacy Policy | Terms & Conditions

Founded in 1982, our vision is that one day,
no one will suffer the full effects of polycystic kidney disease.


International: Canada Canada  France France  Germany Germany  Italy Italy  Japan Japan  United Kingdom United Kingdom